Aptose Biosciences Inc (NAS:APTO)
$ 0.3737 0.0123 (3.4%) Market Cap: 6.62 Mil Enterprise Value: -1.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q1 2021 Aptose Biosciences Inc Earnings Call Transcript

May 04, 2021 / 08:30PM GMT
Release Date Price: $82.35 (-1.61%)
Operator

Good afternoon. My name is Tino, and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences Conference Call for first quarter ended March 31, 2021.

(Operator Instructions)

As a reminder, this conference call may be recorded. I would like to introduce Ms. Susan Pietropaolo. Please go ahead.

Susan M. Pietropaolo
SMP Communications, Inc. - Principal

Thank you, Tino. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the first quarter ended March 31, 2021. I am Susan Pietropaolo, a Communications Representative for Aptose Biosciences. Joining me on the call today are Dr. William G. Rice, Chairman, President and CEO; Dr. Joti Marango, Senior Vice President, Chief Financial Officer and Chief Business Officer; and Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer.

Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot